Stage B2-C metastatic Carcinoma of the Prostate

Drug	Drug Name	Drug Description
DB00499	Flutamide	An antiandrogen used for locally confined stage B2-C and D-2 metastatic prostate carcinoma.

Drug	Drug Name	Target	Type
DB00499	Flutamide	Androgen receptor	target
DB00499	Flutamide	Cytochrome P450 1A2	enzyme
DB00499	Flutamide	Cytochrome P450 3A4	enzyme
DB00499	Flutamide	Cytochrome P450 1A1	enzyme
DB00499	Flutamide	Cytochrome P450 1B1	enzyme
DB00499	Flutamide	Cytochrome P450 3A5	enzyme
DB00499	Flutamide	Aryl hydrocarbon receptor	target
DB00499	Flutamide	Nuclear receptor subfamily 1 group I member 2	target
DB00499	Flutamide	Multidrug resistance-associated protein 1	transporter

Drug	Drug Name	Phase	Status	Count